New stent study aims to keep heart arteries open in routine care

NCT ID NCT03588481

Recruiting now Disease control Sponsor: Seung-Jung Park Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is tracking 1,000 people who receive the DESyne X2 drug-eluting stent to treat narrowed or blocked coronary arteries. Researchers are monitoring how often patients experience serious heart events like death, heart attack, or the need for another procedure. The goal is to see how well the stent works in everyday hospital settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: DESyne X2 drug-eluting coronary stent (novolimus-eluting stent)
What this could lead to: If successful, this study could confirm that the DESyne X2 stent is safe and effective for treating blocked coronary arteries in everyday medical practice.
What could go wrong: This is an observational study, not a controlled trial, so results may be influenced by patient selection or other factors. The stent is already approved, so this is about real-world performance, not a breakthrough.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder Coronary Disease Coronary Occlusion coronary stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY DISEASE CORONARY OCCLUSION CORONARY STENOSIS

Contacts and locations

Locations

Asan Medical Hospital
RECRUITING

Seoul, South Korea
Hallym Hospital
RECRUITING

Incheon, South Korea
Korea University Guro Hospital
TERMINATED

Seoul, South Korea
St.carollo Hospital
TERMINATED

Suncheon, South Korea
The Catholic University of Korea Seoul St. Mary's Hospital
WITHDRAWN

Seoul, South Korea
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
TERMINATED

Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.